Zheng et al. found that ERCC1 rs3212986 was significantly associated with a reduced risk of grade 3-4 hematologic toxicity in recessive model in 437 NSCLC patients (OR = 0.326; 95% CI: 0.123–0.861; p = 0.024) (Zheng et al., 2017). This evidence concerns the gene ERCC1 and non-small cell lung carcinoma.